Free Trial

Quantum Biopharma (QNT) Insider Trading & Ownership

Quantum Biopharma (CVE:QNT) Insider Buying and Selling Activity

Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
C$36.43K
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
C$60.48K
Get QNT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Quantum Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

QNT Insider Buying and Selling by Quarter

Quantum Biopharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/17/2025Anthony John DurkaczDirectorBuy700C$31.17C$21,817.25
7/14/2025Donal CarrollDirectorBuy500C$29.22C$14,608.00
6/3/2025Nathan Patrick CoyleSenior OfficerSell3,000C$20.16C$60,480.00
(Data available from 1/1/2013 forward)

QNT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Quantum Biopharma includes Anthony John Durkacz, Donal Carroll, and Nathan Patrick Coyle. Learn more on insiders at QNT.

The following insiders have purchased QNT shares in the last 24 months: Anthony John Durkacz (C$21,817.25), and Donal Carroll (C$14,608.00).

Insiders have purchased a total of 1,200 QNT shares in the last 24 months for a total of C$36,425.25 bought.

The following insider sold QNT shares in the last 24 months: Nathan Patrick Coyle (C$60,480.00).

Insiders have sold a total of 3,000 Quantum Biopharma shares in the last 24 months for a total of C$60,480.00 sold.



This page (CVE:QNT) was last updated on 7/21/2025 by MarketBeat.com Staff
From Our Partners